JP2008535854A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008535854A5 JP2008535854A5 JP2008505601A JP2008505601A JP2008535854A5 JP 2008535854 A5 JP2008535854 A5 JP 2008535854A5 JP 2008505601 A JP2008505601 A JP 2008505601A JP 2008505601 A JP2008505601 A JP 2008505601A JP 2008535854 A5 JP2008535854 A5 JP 2008535854A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- adam10
- antibody
- level
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US66986205P | 2005-04-07 | 2005-04-07 | |
| PCT/US2006/013156 WO2006110583A2 (en) | 2005-04-07 | 2006-04-07 | Adam10 in cancer diagnosis, detection and treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008535854A JP2008535854A (ja) | 2008-09-04 |
| JP2008535854A5 true JP2008535854A5 (https=) | 2009-05-07 |
Family
ID=37087563
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008505601A Pending JP2008535854A (ja) | 2005-04-07 | 2006-04-07 | 癌の診断、検出および処置におけるａｄａｍ１０ |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090297507A1 (https=) |
| EP (1) | EP1896580A2 (https=) |
| JP (1) | JP2008535854A (https=) |
| AU (1) | AU2006235260A1 (https=) |
| CA (1) | CA2604883A1 (https=) |
| WO (1) | WO2006110583A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160040126A1 (en) * | 2012-02-21 | 2016-02-11 | Korea University Research And Business Foundation | Regulation of differentiation into dopaminergic neurons by metalloprotease |
| KR101485163B1 (ko) | 2012-02-21 | 2015-01-23 | 고려대학교 산학협력단 | 메탈로프로테이즈 ａｄａｍ１７에 의한 도파민성 신경세포로의 분화 조절 조성물 |
| WO2019070685A1 (en) | 2017-10-02 | 2019-04-11 | Verra Therapeutics | METHODS AND COMPOSITIONS FOR INHIBITING BIOLOGICAL ACTIVITIES OF ADAM10 |
| CA3094136A1 (en) | 2018-01-31 | 2019-08-08 | Verra Therapeutics LLC | Methods and compositions for inhibiting adam9 biological activities |
| CN113588940B (zh) * | 2021-07-30 | 2023-05-12 | 菲鹏生物股份有限公司 | 一种提高间接标记灵敏度的方法和试剂盒 |
| CN118987232A (zh) * | 2024-08-08 | 2024-11-22 | 武汉科技大学 | 靶向cd30的car-t细胞与adam10抑制剂联合制备治疗cd30阳性淋巴瘤的药物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1511488B1 (en) * | 2002-06-12 | 2013-05-22 | Symphony Evolution, Inc. | Human adam-10 inhibitors |
-
2006
- 2006-04-07 EP EP06749563A patent/EP1896580A2/en not_active Withdrawn
- 2006-04-07 WO PCT/US2006/013156 patent/WO2006110583A2/en not_active Ceased
- 2006-04-07 CA CA002604883A patent/CA2604883A1/en not_active Abandoned
- 2006-04-07 US US11/918,176 patent/US20090297507A1/en not_active Abandoned
- 2006-04-07 JP JP2008505601A patent/JP2008535854A/ja active Pending
- 2006-04-07 AU AU2006235260A patent/AU2006235260A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Parkkila et al. | The calcium-binding protein S100P in normal and malignant human tissues | |
| JP2009519002A5 (https=) | ||
| CN114599978A (zh) | 使用c-met抑制剂治疗癌症患者的方法 | |
| WO2010017515A2 (en) | Breast cancer specific markers and methods of use | |
| JP2006520781A5 (https=) | ||
| JP2008535856A5 (https=) | ||
| KR20090003308A (ko) | Ｒｅｇ４ 단백질을 이용한 췌장암 진단 방법 | |
| WO2005084109A2 (en) | Cancer specific gene mh15 | |
| CN112626207B (zh) | 一种用于区分非侵袭性和侵袭性无功能垂体腺瘤的基因组合 | |
| KR101925125B1 (ko) | Nckap1을 유효성분으로 포함하는 대장암 진단 또는 대장암 전이 예후 예측용 바이오마커 조성물 | |
| JP2008535855A5 (https=) | ||
| JP2005520543A5 (https=) | ||
| US8747867B2 (en) | Cancer markers | |
| JP2008535854A5 (https=) | ||
| WO2009141440A1 (en) | Netrin-1 overexpression as a biological marker and a survival factor for aggressive neuroblastoma | |
| EP2649204A2 (en) | Novel method of cancer diagnosis and prognosis and prediction of response to therapy | |
| CN112162097B (zh) | Gdf1作为评估pd-1单抗治疗效果的生物标志物 | |
| WO2022022541A1 (zh) | Rbm10基因的用途 | |
| JP2007508020A5 (https=) | ||
| JP2009523004A5 (https=) | ||
| KR102897399B1 (ko) | 유방암 진단을 위한 신규 바이오마커 | |
| JP2008535491A5 (https=) | ||
| CA2865487A1 (en) | Predictive marker of dnmt1 inhibitor therapeutic efficacy and methods of using the marker | |
| JP4967137B2 (ja) | 癌治療用組成物 | |
| WO2007075672A2 (en) | Prognostic cancer markers |